Clinical Study
Efficacy and Tolerability of Travoprost 0.004/Timolol 0.5 Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Figure 1
Study design and patient disposition. ITT, intent-to-treat; TTFC, travoprost 0.004%/timolol 0.5% fixed-dose combination.